Clinical trial No longer in our active list Interventional Ages 18 to 65

Atraumatic hernia repair using TISSIUM™ system

Official title: ALPHA: A Pilot Study to Evaluate the Initial Safety and Performance of the TISSIUM™ Atraumatic Hernia Repair System (TAHRS) for Laparoscopic Hernia Repair

Run by Tissium · NCT06042205 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new hernia repair system to see if it safely and effectively helps people with certain types of hernias during laparoscopic surgery.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment100 (estimated)
SponsorTissium
Industry-sponsored
Drugs / interventionschemotherapy
Locations5 sites (Genk, Limburg and 4 other locations)
Trial IDNCT06042205 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with a midline primary ventral, umbilical, or incisional hernia scheduled for laparoscopic repair.

Probably not a fit

Patients with a BMI over 40, known hypersensitivity to the device materials, or those with multiple hernia defects may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study aims to evaluate the clinical safety and performance of the TISSIUM™ Atraumatic Hernia Repair System (TAHRS) in patients undergoing laparoscopic repair for midline primary ventral, umbilical, or incisional hernias. Participants will be assessed for their ability to have their hernia repaired with a specific overlap of mesh. The study will capture preliminary data on the effectiveness and safety of this innovative repair system.

Why it matters

Potential benefit: If successful, this approach could provide a safer and more effective method for hernia repair, potentially reducing recovery time and complications.

How similar studies have gone: While this study explores a novel approach, similar interventions in hernia repair have shown promise in improving outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Key Inclusion Criteria:

1. Subject is 18 years old or older;
2. Patient willing and able to provide a signed Patient Informed Consent Form;
3. Has a midline primary ventral, umbilical or incisional hernia;
4. Scheduled for a laparoscopic IPOM hernia repair;
5. Hernia can be successfully repaired with at least a 5 cm overlap of the mesh on all sides of the defect

Key Exclusion Criteria:

1. Patient has a known or suspected hypersensitivity to the constituent polymer of the investigational device, mesh, or other surgical products (e.g., sutures);
2. BMI \> 40;
3. Patient is a current smoker, defined as self-reporting smoking more than 1 cigarette per day;
4. Patient is taking systemic immunosuppressive medications, systemic steroids, or chemotherapy at the time of informed consent;
5. Patient is pregnant, plans to become pregnant during the study period, or is breastfeeding;
6. Patient with Type 1 or uncontrolled Type 2 Diabetes Mellitus;
7. Patient has more than one hernia defect (to be confirmed intraoperatively);

Where it's running

  • Ziekenhuis Oost-Limburg [ZOL]
    Genk, Limburg, Belgium
    Recruiting
  • Imelda Hospital
    Bonheiden, Belgium
    Recruiting
  • CHU UCL Namur
    Yvoir, Belgium
    Recruiting
  • Universitary Hospital Virgen Macarena
    Seville, Spain
    Recruiting
  • AZ Sint-Jan
    Ruddershove, Belgium
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.